EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Differential O -glucose elongation on a specific EGF repeat within the canonical ligand–binding domain regulates DLL1/4-NOTCH1 signaling

Yohei Tsukamoto iD, Kazuhiro Aoki, Yuichi Kama iD, Hiroyuki Hosokawa iD, Wataru Saiki iD, Natsumi Tsukamoto, Koki Kato, Yohei Hosokawa, Rie Sato, Naoki Uesugi, Yuki Fujita, Kana Fukazawa und 12 weitere

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2504827122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Yohei Tsukamoto und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biochemistry, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan. Hauptthemen laut MEDLINE: Receptor, Notch1, Signal Transduction, Glucose, Membrane Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), Takeda Science Foundation (TSF), Yamada Science Foundation (YSF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Three types of O -linked glycosylation— O -glucose, O -fucose, and O - N -acetylglucosamine— are crucial for the function of Notch receptors, which regulate critical cell fate determination processes in a wide variety of contexts. O -Glucose glycans are transferred to serine residues located between the first and second conserved cysteines within the epidermal growth factor-like (EGF) repeats in the Notch extracellular domain. Previously, O -glucose glycans were shown to be extended to a trisaccharide structure with two xyloses via α1-3 linkages. Our recent studies, however, indicated that the O -glucose glycan on NOTCH1 EGF10 can be extended by hexose and Neu5Ac. Here, we demonstrated that this hexose- and Neu5Ac-extended glycan has a 3’-sialyllactose-like structure synthesized by specific members of two isoenzyme families, B4GALT1 and ST3GAL4. Using mass spectrometry, we identified this modification exclusively on NOTCH1 EGF10 and the analogous NOTCH3 EGF9 domain, with no detection in any other EGF domains in NOTCH1, NOTCH2, and NOTCH3. Sequence comparison and mutagenesis experiments identified one amino acid at position -2 of the fourth cysteine (C 4 -2) in the EGF domain as crucial for the galactose elongation of O -glucose glycans. We further demonstrated that this site-specific elongation of O -glucose on NOTCH1 EGF10 significantly impacts ligand binding and signal transduction of NOTCH1. In the context of early T cell development, the C 4 -2 mutants NOTCH1 A396Y and A396F enhance T cell differentiation through DLL1- and DLL4-dependent NOTCH1 signaling. Our findings contribute to the understanding of the intricate regulatory mechanisms of Notch receptor function mediated by distinct positions and structures of O -glycans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Notch1Signal TransductionGlucoseMembrane ProteinsIntercellular Signaling Peptides and ProteinsHumansCalcium-Binding ProteinsAnimalsGlycosylationMiceLigandsProtein DomainsEpidermal Growth FactorPolysaccharides

Stichwörter der Autor:innen

glycosylationglycosyltransferasenotch signaling

Substanzen

Receptor, Notch1GlucoseCalcium-Binding ProteinsMembrane ProteinsIntercellular Signaling Peptides and ProteinsLigandsDlk1 protein, mouseEpidermal Growth FactorPolysaccharidesNOTCH1 protein, human

Autor:innen und Institutionen

  • Department of Molecular Biochemistry, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
  • Complex Carbohydrate Research Center, University of Georgia, Athens, GA 30602.
  • Department of Immunology, Tokai University School of Medicine, Isehara 259-1193, Japan.
  • Department of Functional Morphology, Faculty of Pharmacy, Juntendo University, Chiba 279-0013, Japan.
  • Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen N 2200, Denmark.

ORCID-Profile: Yohei Tsukamoto, Yuichi Kama, Hiroyuki Hosokawa, Wataru Saiki, Yusuke Urata, Akira Minami, Michael Tiemeyer, Yoshiki Narimatsu, Hideyuki Takeuchi

Förderung

  • MEXT | Japan Society for the Promotion of Science (JSPS)
  • Takeda Science Foundation (TSF)
  • Yamada Science Foundation (YSF)
  • KU | Novo Nordisk Foundation Center for Protein Research, University of Copenhagen (CPR)
  • Danmarks Grundforskningsfond (DNRF)
  • YOKOYAMA Foundation for Clinical Pharmacology ()

Zitieren

APA

Tsukamoto, Y., Aoki, K., Kama, Y., Hosokawa, H., Saiki, W., Tsukamoto, N., Kato, K., Hosokawa, Y., Sato, R., Uesugi, N., Fujita, Y., Fukazawa, K., Funada, D., Suzuki, F., Kurebayashi, Y., Urata, Y., Uchiyama, S., Wang, W., Minami, A., …, & Takeuchi, H. (2025). Differential O -glucose elongation on a specific EGF repeat within the canonical ligand–binding domain regulates DLL1/4-NOTCH1 signaling. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2504827122

Vancouver

Tsukamoto Y, Aoki K, Kama Y, Hosokawa H, Saiki W, Tsukamoto N, et al. Differential O -glucose elongation on a specific EGF repeat within the canonical ligand–binding domain regulates DLL1/4-NOTCH1 signaling. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2504827122

BibTeX
@article{Tsukamoto2025,
  author = {Tsukamoto, Yohei and Aoki, Kazuhiro and Kama, Yuichi and Hosokawa, Hiroyuki and Saiki, Wataru and Tsukamoto, Natsumi and Kato, Koki and Hosokawa, Yohei and Sato, Rie and Uesugi, Naoki and Fujita, Yuki and Fukazawa, Kana and Funada, Daichi and Suzuki, Fuga and Kurebayashi, Yuuki and Urata, Yusuke and Uchiyama, Sae and Wang, Weiwei and Minami, Akira and Takahashi, Tadanobu and Tiemeyer, Michael and Narimatsu, Yoshiki and Okajima, Tetsuya and Takeuchi, Hideyuki},
  title = {Differential O -glucose elongation on a specific EGF repeat within the canonical ligand–binding domain regulates DLL1/4-NOTCH1 signaling},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2504827122}
}
Kostenlos starten →